Skip to main content
SMFM 2025 Pregnancy Meeting Main banner
Final Program


Program Book
Icon Legend
Presentation Icons
Additional registration fee required
Additional registration fee required
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Recording
Recording
Poster Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared on social media
Faculty have requested this content not be shared on social media
CME Credit Offered
CME Credit Offered
Abstract Award
Abstract Award
Back

Clinically Relevant Prenatal Genetics Updates for the Practicing Maternal Fetal Medicine Provider

Postgraduate Courses

Clinically Relevant Prenatal Genetics Updates for the Practicing Maternal Fetal Medicine Provider

Clinical use of cell free fetal DNA in prevention and management of red cell alloimmunization.

Monday, January 27, 2025
3:30 PM – 4:00 PM  
Location: Aurora Ballroom C, Lobby Level

Learning Objectives:

  • Describe the genetics of the most common red cell antigens associated with hemolytic disease of the fetus and newborn
  • Review the effectiveness of cell free fetal DNA for determination of fetal red cell antigen status
  • Present guidelines for interpretation of cell free fetal antigen status for use in prevention of D alloimmunization and management in sensitized pregnancies.